Barish Edil to Aged, 80 and over
This is a "connection" page, showing publications Barish Edil has written about Aged, 80 and over.
Connection Strength
0.919
-
Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy? J Am Coll Surg. 2018 07; 227(1):55-62.
Score: 0.106
-
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram. Ann Surg. 2014 Feb; 259(2):204-12.
Score: 0.079
-
Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012 Nov; 36(11):1666-73.
Score: 0.073
-
Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. Oncologist. 2024 Aug 05; 29(8):690-698.
Score: 0.041
-
Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers. Ann Surg. 2019 12; 270(6):1147-1155.
Score: 0.030
-
Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. J Surg Oncol. 2018 Apr; 117(5):1073-1083.
Score: 0.026
-
Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. J Am Coll Surg. 2017 Mar; 224(3):362-372.
Score: 0.024
-
NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Netw. 2016 11; 14(11):1357-1370.
Score: 0.024
-
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2016 Feb; 39(1):18-26.
Score: 0.023
-
Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study. Gastrointest Endosc. 2015 Dec; 82(6):1060-9.
Score: 0.022
-
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol. 2013 Nov; 37(11):1671-7.
Score: 0.019
-
Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S725-30.
Score: 0.019
-
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):678-85.
Score: 0.019
-
Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. AJR Am J Roentgenol. 2013 Mar; 200(3):W283-90.
Score: 0.019
-
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning. Radiother Oncol. 2012 Aug; 104(2):167-72.
Score: 0.018
-
Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. Surgery. 2012 Aug; 152(2):218-26.
Score: 0.018
-
Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012 Aug; 16(8):1478-86.
Score: 0.018
-
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol. 2012 Jul; 25(7):1033-9.
Score: 0.018
-
Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma. J Surg Oncol. 2012 Jul 01; 106(1):66-71.
Score: 0.017
-
Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012 Feb; 255(2):326-33.
Score: 0.017
-
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012 Feb; 36(2):173-84.
Score: 0.017
-
Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012 Apr; 214(4):390-8; discussion 398-9.
Score: 0.017
-
Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. Hum Pathol. 2012 Aug; 43(8):1169-76.
Score: 0.017
-
Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012 Jun; 19(6):1928-35.
Score: 0.017
-
Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012 May 15; 118(10):2674-81.
Score: 0.017
-
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg. 2011 Nov; 15(11):1917-27.
Score: 0.017
-
The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg. 2011 Jun; 35(6):1345-54.
Score: 0.016
-
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford). 2011 Jul; 13(7):473-82.
Score: 0.016
-
Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol. 2011 Jun 01; 103(7):656-62.
Score: 0.016
-
EUS-guided tattooing before laparoscopic distal pancreatic resection (with video). Gastrointest Endosc. 2010 Nov; 72(5):1089-94.
Score: 0.016
-
National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010 Oct; 14(10):1578-91.
Score: 0.016
-
Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol. 2010 Sep 01; 102(3):256-63.
Score: 0.016
-
Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Ann Surg Oncol. 2010 Dec; 17(12):3112-9.
Score: 0.016
-
Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg. 2010 Jul; 252(1):142-8.
Score: 0.015
-
Preoperative endoscopic tattooing of pancreatic body and tail lesions decreases operative time for laparoscopic distal pancreatectomy. Surgery. 2010 Aug; 148(2):371-7.
Score: 0.015
-
Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010 Mar; 251(3):470-6.
Score: 0.015
-
Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg. 2010 Feb; 14(2):379-87.
Score: 0.015
-
Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009 Aug; 250(2):282-7.
Score: 0.015